Spatial mapping of hepatitis C prevalence in recent injecting drug users in contact with services. [PDF]
, 2011 In developed countries the majority of hepatitis C virus (HCV) infections occur in injecting drug users (IDUs) with prevalence in IDUs often high, but with wide geographical differences within countries.
A. MORONGIU +13 more
core +1 more source
The Utility of ANTI-HCV S/CO Ratio, HCV-RNA and ALT Test in Predicting Viremia in ANTI-HCV Positive Patients [PDF]
Türk Biyokimya Dergisi, 2007 Hepatitis C Virus (HCV) infection is frequently diagnosed by detection of antibodyagainst the HCV (Anti-HCV). The seropositivity of anti-HCV could reflect chronicinfectious status and/or previous infection.
Tuğrul Himmetoğlu +5 more
doaj
Hepatitis C testing and status among opioid substitution treatment clients in New South Wales
Australian and New Zealand Journal of Public Health, 2014 Background: In Australia about half of the people who inject drugs (PWID) are hepatitis C (HCV) antibody positive (anti‐HCV+). The prevalence among opioid substitution treatment (OST) clients specifically is unclear, despite OST clinics being a potential
Fiona L. Shand +5 more
doaj +1 more source
Hepatitis C viremia patterns in incident hepatitis C infection and one year later in 150 prospectively tested persons who inject drugs. [PDF]
PLoS ONE, 2014 OBJECTIVES: To assess HCV viremia levels just before, during and one year after anti-HCV seroconversion in people who inject drugs (PWID). METHODS: PWID enrolling into a needle exchange program in Malmö, Sweden, 1997-2005 constituted the source ...
Marianne Alanko Blomé +4 more
doaj +1 more source
Low levels of hepatitis C diagnosis and testing uptake among people who inject image and performance enhancing drugs in England and Wales, 2012-15 [PDF]
, 2017 People injecting image and performance enhancing drugs (IPEDs) have traditionally not been perceived as being at high risk of hepatitis C virus (HCV) infection.
Desai, M +8 more
core +2 more sources
Acta Pharmaceutica Sinica B, 2016 Unlike human immunodeficiency virus (HIV) and hepatitis B virus (HBV), hepatitis C virus (HCV) infection is a curable disease. Current direct antiviral agent (DAA) targets are focused on HCV NS3/4A protein (protease), NS5B protein (polymerase) and NS5A protein.
openaire +3 more sources
HCV-RNA and Anti-HCV IgM in Egyptian Subjects Bearing IgG Anti-HCV Antibodies
Japanese Journal of Infectious Diseases, 1999 The hepatitis C virus (HCV) infection is associated with a wide spectrum of clinical entities ranging from asymptomatic carriage to severe forms of chronic hepatitis. In Egypt, HCV infection has been shown to be highly prevalent. The aim of this study was to determine the frequency and significance of anti-HCV IgM in the sera of clinically healthy ...
A, el-Gohary +6 more
openaire +3 more sources
Kaohsiung Journal of Medical Sciences, 2011 We evaluated the performance of a hepatitis C virus (HCV) antigen/antibody combination test [Murex HCV Antigen/Antibody Combination Test (Murex Ag/Ab test)] by comparing it with the current third-generation HCV antibody enzyme immunoassay (anti-HCV).
Jeng-Fu Yang +11 more
doaj +1 more source
The prevalence of hepatitis C virus among people of South Asian origin in Glasgow: results from a community based survey and laboratory surveillance [PDF]
, 2013 Background South Asians often present late with HCV or HBV related liver disease which could have been avoided with early diagnosis and subsequent treatment; however the prevalence of HCV/HBV among South Asians in Glasgow is not known.
Ahmed, S. +14 more
core +2 more sources
Anti-HCV prevalence in the general population of Lithuania [PDF]
Medical Science Monitor, 2012 The aim of this study was to assess risk factors for HCV acquisition and prevalence of anti-HCV in the general population of Lithuania.The study enrolled 1528 randomly selected adults from the 5 biggest cities of Lithuania and its rural regions.
Liakina, Valentina, Valantinas, Jonas
openaire +3 more sources